Abt, M. C., McKenney, P. T., & Pamer, E. G. (2016). Clostridium difficile colitis: Pathogenesis and host defence. Nature Reviews: Microbiology, 14, 609–620.

PubMed  CAS  Google Scholar 

Afzaal, M., Saeed, F., Shah, Y. A., Hussain, M., Rabail, R., Socol, C. T., Hassoun, A., Pateiro, M., Lorenzo, J. M., Rusu, A. V., et al. (2022). Human gut microbiota in health and disease: Unveiling the relationship. Frontiers in Microbiology, 13, 999001.

Article  PubMed  PubMed Central  Google Scholar 

Ahlawat, S., & Asha, & Sharma, K. K. (2021). Gut-organ axis: A microbial outreach and networking. Letters in Applied Microbiology, 72, 636–668.

Article  PubMed  CAS  Google Scholar 

Albillos, A., de Gottardi, A., & Rescigno, M. (2020). The gut-liver axis in liver disease: Pathophysiological basis for therapy. Journal of Hepatology, 72, 558–577.

Article  PubMed  CAS  Google Scholar 

Bartlett, J. G., Tedesco, F. J., Shull, S., Lowe, B., & Chang, T. (1980). Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. Gastroenterology, 78, 431–434.

Article  PubMed  CAS  Google Scholar 

Baunwall, S. M. D., Dahlerup, J. F., Engberg, J. H., Erikstrup, C., Helms, M., Juel, M. A., Kjeldsen, J., Nielsen, H. L., Nilsson, A. C., Rode, A. A., et al. (2021). Danish national guideline for the treatment of Clostridioides difficile infection and use of faecal microbiota transplantation (fmt). Scandinavian Journal of Gastroenterology, 56, 1056–1077.

Article  PubMed  CAS  Google Scholar 

Biazzo, M., & Deidda, G. (2022). Fecal microbiota transplantation as new therapeutic avenue for human diseases. Journal of Clinical Medicine, 11, 4119.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bloom, P. P., Donlan, J., Torres Soto, M., Daidone, M., Hohmann, E., & Chung, R. T. (2022). Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient. Hepatology Communications, 6, 2079–2089.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Borody, T. J., George, L., Andrews, P., Brandl, S., Noonan, S., Cole, P., Hyland, L., Morgan, A., Maysey, J., & Moore-Jones, D. (1989). Bowel-flora alteration: A potential cure for inflammatory bowel disease and irritable bowel syndrome? Medical Journal of Australia, 150, 604.

Article  PubMed  CAS  Google Scholar 

Brandt, L. J., Aroniadis, O. C., Mellow, M., Kanatzar, A., Kelly, C., Park, T., Stollman, N., Rohlke, F., & Surawicz, C. (2012). Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. American Journal of Gastroenterology, 107, 1079–1087.

Article  PubMed  Google Scholar 

Brunse, A., Deng, L., Pan, X., Hui, Y., Castro-Mejia, J. L., Kot, W., Nguyen, D. N., Secher, J. B., Nielsen, D. S., & Thymann, T. (2022). Fecal filtrate transplantation protects against necrotizing enterocolitis. The ISME Journal, 16, 686–694.

Article  PubMed  CAS  Google Scholar 

Cammarota, G., Ianiro, G., Kelly, C. R., Mullish, B. H., Allegretti, J. R., Kassam, Z., Putignani, L., Fischer, M., Keller, J. J., Costello, S. P., et al. (2019). International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut, 68, 2111–2121.

Article  PubMed  CAS  Google Scholar 

Cammarota, G., Ianiro, G., Tilg, H., Rajilic-Stojanovic, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017). European consensus conference on faecal microbiota transplantation in clinical practice. Gut, 66, 569–580.

Article  PubMed  Google Scholar 

Carlson, P. E. (2020). Regulatory considerations for fecal microbiota transplantation products. Cell Host & Microbe, 27, 173–175.

Article  CAS  Google Scholar 

Chang, T.-W., Gorbach, S. L., Bartlett, J. G., & Saginur, R. (1980). Bacitracin treatment of antibiotic-associated colitis and diarrhea caused by Clostridium difficile toxin. Gastroenterology, 78, 1584–1586.

Article  PubMed  CAS  Google Scholar 

Chen, J., Zaman, A., Ramakrishna, B., & Olesen, S. W. (2021). Stool banking for fecal microbiota transplantation: Methods and operations at a large stool bank. Frontiers in Cellular and Infection Microbiology, 11, 622949.

Article  PubMed  PubMed Central  Google Scholar 

Chen, Q., Fan, Y., Zhang, B., Yan, C., Zhang, Q., Ke, Y., Chen, Z., Wang, L., Shi, H., Hu, Y., et al. (2023). Capsulized fecal microbiota transplantation induces remission in patients with ulcerative colitis by gut microbial colonization and metabolite regulation. Microbiolgy Spectrum, 11, e0415222.

Article  Google Scholar 

Chu, N. D., Smith, M. B., Perrotta, A. R., Kassam, Z., & Alm, E. J. (2017). Profiling living bacteria informs preparation of fecal microbiota transplantations. PLoS ONE, 12, e0170922.

Article  PubMed  PubMed Central  Google Scholar 

Cold, F., Svensson, C. K., Petersen, A. M., Hansen, L. H., & Helms, M. (2022). Long-term safety following faecal microbiota transplantation as a treatment for recurrent Clostridioides difficile infection compared with patients treated with a fixed bacterial mixture: Results from a retrospective cohort study. Cells, 11, 435.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cox, L. M., Yamanishi, S., Sohn, J., Alekseyenko, A. V., Leung, J. M., Cho, I., Kim, S. G., Li, H., Gao, Z., Mahana, D., et al. (2014). Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell, 158, 705–721.

Article  PubMed  PubMed Central  CAS  Google Scholar 

De Groot, P. F., Frissen, M., De Clercq, N., & Nieuwdorp, M. (2017). Fecal microbiota transplantation in metabolic syndrome: History, present and future. Gut Microbes, 8, 253–267.

Article  PubMed  PubMed Central  Google Scholar 

DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L. (2019). Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. New England Journal of Medicine, 381, 2043–2050.

Article  PubMed  Google Scholar 

Doron, S., & Snydman, D. R. (2015). Risk and safety of probiotics. Clinical Infectious Diseases, 60(Suppl 2), S129-134.

Article  PubMed  PubMed Central  Google Scholar 

Du, C., Luo, Y., Walsh, S., & Grinspan, A. (2021). Oral fecal microbiota transplant capsules are safe and effective for recurrent Clostridioides difficile infection: A systematic review and meta-analysis. Journal of Clinical Gastroenterology, 55, 300–308.

Article  PubMed  CAS  Google Scholar 

Du, H., Kuang, T.-T., Qiu, S., Xu, T., Gang Huan, C.-L., Fan, G., & Zhang, Y. (2019). Fecal medicines used in traditional medical system of china: A systematic review of their names, original species, traditional uses, and modern investigations. Chinese Medicine, 14, 1–16.

Article  Google Scholar 

Eiseman, B., Silen, W., Bascom, G. S., & Kauvar, A. J. (1958). Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery, 44, 854–859.

PubMed  CAS  Google Scholar 

El-Salhy, M., Gilja, O. H., & Hatlebakk, J. G. (2024). Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome. Neurogastroenterology and Motility, 36, e14641.

Article  PubMed  Google Scholar 

El-Salhy, M., Hatlebakk, J. G., Gilja, O. H., Brathen Kristoffersen, A., & Hausken, T. (2020). Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut, 69, 859–867.

Article  PubMed  CAS  Google Scholar 

El-Salhy, M., Kristoffersen, A. B., Valeur, J., Casen, C., Hatlebakk, J. G., Gilja, O. H., & Hausken, T. (2022). Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome. Neurogastroenterology and Motility, 34, e14200.

Article  PubMed  CAS  Google Scholar 

Eom, T., Kim, Y. S., Choi, C. H., Sadowsky, M. J., & Unno, T. (2018). Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease. Journal of Microbiology, 56, 189–198.

Article  PubMed  CAS  Google Scholar 

Federici, S., Kredo-Russo, S., Valdes-Mas, R., Kviatcovsky, D., Weinstock, E., Matiuhin, Y., Silberberg, Y., Atarashi, K., Furuichi, M., Oka, A., et al. (2022). Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation. Cell, 185, 2879-2898.e24.